Team |
Tyler Smith, PhD
Tyler Smith, PhD

Tyler Smith, PhD


Technology Development

Tyler is responsible for developing and optimizing RNA production processes for mRNA-based products at Life Edit Therapeutics.

Prior to joining Life Edit, Tyler was a scientist at Enumera Molecular where he was responsible for the development of nucleic acid-based diagnostic platforms with applications for NIPT, oncology, infectious disease and more.

Tyler received his PhD in Chemistry from the University of Michigan, where he studied how unique sequence motifs (e.g., internal polyA) and nucleotide chemical modifications (e.g., m6A and m5U) in mRNA and tRNA impact rates, efficiency and accuracy of protein synthesis.

Connect with

Visionary science, driven by visionary values.

Our Mission

To rewrite the future by curing disease, making any edit, anywhere.

Our Vision

To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.

Our Values

We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.